ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients
Clinical trial NCT06844136 · RECRUITING
Trial details
- NCT number
- NCT06844136
- Sponsor
- Pierian Biosciences
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-22
- Primary completion
- 2026-07-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.